Agenus Inc
Biotechnology
Healthcare
AGEN
28.12 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
4.51
52 week high
7.06
high
4.67
52 week low
0.00
previous Close
4.60
P/E ratio
-4
market cap
132 M
div yield
0
net incoming
-28.01 M
-10.62 %
net profit margin
-109.02 %
-3.00 %
operating incoming
9.60 M
172.09 %
net change in cash
-8.95 M
59.21 %
cash on hand
9.53 M
-48.43 %
cost of revenue
243 K
77.37 %
top